Skip to main content
Equibles

Saturn V Capital Management LP

Position in CADL — Candel Therapeutics, Inc.

CIK 1964437 AUSTIN, TX
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$34,027,965
+$19,834,684 QoQ
Shares Held
3,303,686
+14.1% QoQ
Ownership
4.32%
of shares outstanding
% of Portfolio
4.88%
of 13F equity value
Holder Rank
#7
of 138 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Saturn V Capital Management LP holds $614,415,149 across 22 Biotechnology names. CADL ranks #9 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALMS
Alumis Inc.
 2,915,443 $82,040,566
2 ABVX
Abivax S.A.
 518,865 $69,143,949
3 PCVX
Vaxcyte, Inc.
 852,914 $49,579,890
4 IMMX
Immix Biopharma, Inc.
 4,658,429 $48,028,402
5 PHVS
Pharvaris N.V.
 1,314,122 $45,442,338
6 JAZZ
Jazz Pharmaceuticals plc
 160,938 $38,781,229
7 CELC
Celcuity Inc.
 370,318 $38,742,669
8 IRON
Disc Medicine, Inc.
 524,730 $38,378,752

All Filings in CADL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,027,965 3,303,686
2026-03-31 $14,193,281 2,896,588